MedTrace Logo

HR Chest CT Visual Scoring, Spirometry and Health Related Quality of Life in Evaluating Severity of ILD Patients

NCT05999838 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-08-21

No results posted yet for this study

Summary

To establish a simplified approach for assessment of severity of interstitial lung disease by evaluating the relationship between HRCT findings, the clinical severity score,spirometry and quality of life.

Conditions

Interventions

DIAGNOSTIC_TEST

HRCT chest visual scoring

CT-based semi-quantitative scoring will be calculated according to number of lung segments affected on both sides. The finding on each segment will be given a score from 1 to 4 as follows: 1. for ground glass opacities. 2. for reticulations and fibrotic changes. 3. for bronchiectatic changes. 4. for honeycombing and sub-pleural cysts.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2024-10-31
Completion
2025-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05999838 on ClinicalTrials.gov